170885 ⎘
Detection or diagnosis of diseases; Gynecology or obstetrics Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
IDENTIFICATION AND QUANTIFICATION OF BIOMARKERS FOR EVALUATING THE RISK OF PRETERM BIRTH
#302Adam12, A Novel Marker For Abnormal Cell Function
#303BIOMARKERS AND PARAMETERS FOR HYPERTENSIVE DISORDERS OF PREGNANCY
#304DIAGNOSTIC METHOD FOR DETERMINING THE SUSCEPTIBILITY TO DELIVERY AND REAGENT KIT FOR USE THEREOF
#305Methods for determining maternal health risks
#306METHODS AND KITS FOR ISOLATING PLACENTAL DERIVED MICROPARTICLES AND USE OF SAME FOR DIAGNOSIS OF FETAL DISORDERS
#307Methods of administering PIF agonist peptides and uses thereof
#308Recombinant soluble truncated IL-23 receptor (IL-23R) capable of inhibiting IL-23R-mediated cell signaling
#309METHODS TO DIAGNOSE A REQUIRED REGULATION OF TROPHOBLAST INVASION
#310Detection of amniotic fluid in vaginal secretions of pregnant women due to premature rupture of fetal membranes
#311Diagnosis of preeclampsia
#312Methods for detecting oncofetal fibronectin
#313Markers for detection of complications resulting from in utero encounters
#314Devices and methods for detecting amniotic fluid in vaginal secretions
#315METHOD OF SCREENING PLACENTAL PROTEINS RESPONSIBLE FOR PATHOPHYSIOLOGY OF PREECLAMPSIA, AND MARKER FOR EARLY DIAGNOSIS AND PREDICTION OF PREECLAMPSIA
#316Methods for predicting pregnancy outcome in a subject by hCG assay
#317METHOD FOR DETERMINING THE RISK OF PREECLAMPSIA USING PIGF-2 AND PIGF-3 MARKERS
#318Prediction and prevention of preeclampsia
#319Methods and kits for detecting misfolded proteins
#320BIOMARKERS FOR HYPERTENSIVE DISORDERS OF PREGNANCY
#321IDENTIFYING AND QUANTIFYING BIOMARKERS ASSOCIATED WITH PREECLAMPSIA
#322METHODS OF DIAGNOSING AND TREATING COMPLICATIONS OF PREGNANCY
#323Inhibitors
#324Method to determine state of a cell exchanging metabolites with a fluid medium by analyzing the metabolites in the fluid medium
#325TOTAL PLASMA FVII/FVIIA LEVELS AS INDICATORS OF PRE-ECLAMPSIA OF PREGNANT FEMALES
#326METHODS FOR REDUCING THE LIKELIHOOD OF SPONTANEOUS ABORTION DURING ASSISTED REPRODUCTION IN A SUBJECT
#327Methods and Kits for Predicting the Onset of Labour
#328Marker for inflammatory conditions
#329Use of the IRAP protein for implementing methods of diagnosis and of prognosis
#330Methods and kits for detecting ITA in a biological sample
#331Detection of intraamniotic infection
#332METHODS AND MATERIALS FOR IDENTIFYING POLYMORPHIC VARIANTS, DIAGNOSING SUSCEPTIBILITIES, AND TREATING DISEASE
#333Methods for predicting pregnancy outcome in a subject by hCG assay
#334PRETERM DELIVERY DIAGNOSTIC ASSAY
#335Soluble CD117 () for diagnosis of preeclampsia and eclampsia
#336COMPOSITIONS AND METHODS FOR REDUCING THE LIKELIHOOD OF PREECLAMPSIA IN RECIPIENTS OF ARTIFICIAL INSEMINATION
#337COMPOSITIONS AND METHODS FOR REDUCING THE LIKELIHOOD OF PRETERM LABOR IN RECIPIENTS OF ARTIFICIAL INSEMINATION
#338METHODS AND KITS FOR REDUCING THE LIKELIHOOD OF IMPLANTATION FAILURE AND PREGNANCY-RELATED DISORDERS IN RECIPIENTS OF ARTIFICIAL INSEMINATION
#339COMPOSITIONS AND METHODS FOR REDUCING THE LIKELIHOOD OF SPONTANEOUS ABORTION IN RECIPIENTS OF ARTIFICAL INSEMINATION
#340Detection of risk of pre-eclampsia
#341Serum-based, diagnostic, biological assay to predict pregnancy disorders
#342METHOD OF IMMUNOLOGICAL ANALYSIS FOR DETECTION OF ANTIBODIES AGAINST HUMAN GSTT1 (ANTI-HGSTT1)
#343NOVEL METHOD FOR DIAGNOSING PREGNANCY-RELATED COMPLICATIONS
#344METHODS OF TREATING PRE-ECLAMPSIA OR ECLAMPSIA
#345EMBRYO IMPLANTATION
#346Compositions and methods for early pregnancy diagnosis
#347Devices and methods for detecting amniotic fluid in vaginal secretions
#348Methods for determining the risk of prenatal complications
#349Identification and quantification of biomarkers for evaluating the risk of preterm birth
#350Method for diagnosing an increased risk of preeclampsia by measuring the level of HIF-α
#351Peptide Markers for Diagnosis of Preeclampsia
#352IDENTIFICATION OF ECTOPIC PREGNANCIES
#353Marker for inflammatory conditions
#354Peptide Markers for Diagnosis of Angiogenesis
#355Diagnosis of preeclampsia
#356BIOMARKERS FOR PREECLAMPSIA
#357ADAM12, a novel marker for abnormal cell function
#358Hypoxia related genes and proteins for the treatment and diagnosis of pregnancy related complications
#359METHOD FOR REDUCING THE LIKELIHOOD OF PRETERM LABOR IN A SUBJECT IN NEED THEREOF
#360METHOD FOR REDUCING THE LIKELIHOOD OF PREECLAMPSIA IN A SUBJECT IN NEED THEREOF
#361METHODS FOR DETECTION OF PREECLAMPSIA
#362Biomarker for the Medicine and the Biology of the Reproduction
#363Diagnosis and treatment of preeclampsia
#364Diagnostic method for determining the susceptibility to delivery and reagent kit for use therefor
#365Method for reducing the risk of spontaneous abortion in a human female subject
#366Labor biomarkers, methods comprising same, and methods targeting same
#367Urinary proteomic biomarker patterns in preeclampsia
#368MULTIPLEXED DIAGNOSTIC TEST FOR PRETERM LABOR
#369APPLICATION OF SURFACE PLASMON RESONANCE TECHNOLOGY TO MATERNAL SERUM SCREENING FOR CONGENITAL BIRTH DEFECTS
#370MATERNAL SERUM BIOMARKERS FOR DETECTION OF PRE-ECLAMPSIA
#371Methods and kits to detect and monitor ovarian cancer and preeclampsia
#372Early Diagnosis of Congenital Abnormalities in the Offspring of Diabetic Mothers
#373Methods of Diagnosing and Treating Complications of Pregnancy
#374Methods for the Diagnosis and Treatment of Preeclampsia
#375DIAGNOSTIC METHOD FOR DETERMINING THE SUSCEPTIBILITY TO DELIVERY AND REAGENT KIT FOR USE THEREFOR
#376ANTIPROLIFERATIVE PEPTIDES AND ANTIBODIES FOR THEIR DETECTION
#377DIAGNOSTIC COMPOSITIONS AND TREATMENT METHODS FOR CONDITIONS INVOLVING TROPHOBLAST CELL DEATH, DIFFERENTIATION, INVASION AND/OR CELL FUSION AND TURNOVER
#378Polynucleotides and polypeptides associated with trophoblast cell death, differentiation, invasion, and/or cell fusion and turnover
#379Method of diagnosis of pregnancy-related complications
#380COMPOSITIONS AND METHODS FOR REDUCING THE LIKELIHOOD OF IMPLANTATION FAILURE OR MISCARRIAGE IN RECIPIENTS OF ARTIFICIAL INSEMINATION
#381Marker for inflammatory conditions
#382DIAGNOSIS OF FETAL ABNORMALITIES USING NUCLEATED RED BLOOD CELLS
#383Determination of sFlt-1:angiogenic factor complex
#384Kits for the diagnosis of pre-eclampsia or eclampsia
#385Method of determining pregnancy toxemia
#386MARKERS FOR PREECLAMPSIA
#387Methods and kits for detecting ITA in a biological sample
#388Methods for early diagnosing of an increased risk of preeclampsia
#389Procedure for the determination of the activity of the protease which activates factor VII from protein solutions
#390DISCRIMINATON OF CARDIAC DYSFUNCTION IN PREGNANT FEMALES
#391PIF peptides biologic activities, site of action, and the antibody to detect PIF
#392Method for reducing the likelihood of implantation failure during assisted reproduction in a subject
#393Methods for predicting embryo viability
#394PREGNANCY-RELATED ENZYME ACTIVITY
#395MARKERS FOR PREECLAMPSIA
#396Methods of diagnosing leiomyoma by measuring catechol-O-methyltransferase
#397Platelet biomarkers for cancer
#398Method for reducing the likelihood of spontaneous abortion presenting a sign or symptom of threatened abortion
#399COMPOSITIONS AND METHODS FOR HEALTHY PREGNANCY
#400Method for reducing the likelihood of implantation failure during an assisted reproduction in a subject in need thereof
#401Method of screening placental proteins responsible for pathophysiology of preeclampsia, and marker for early diagnosis and prediction of preeclampsia
#402Methods of diagnosing pre-eclampsia or eclampsia
#403Diagnostic test for inflammatory endothelial dysfunctions in pregnancies
#404Methods of Employing Vascular Leakage to Diagnose a Capillary Leak Disorder
#405Non-invasive prenatal genetic diagnosis using transcervical cells
#406Assay
#407Salivary Protease Assays for Identifying Increased Risk of Preterm Delivery Induced by Premature Rupture of Fetal Membranes
#408Methods and Kits For Predicting Risk For Preterm Labor
#409BIOMARKERS FOR PREECLAMPSIA
#410Methods For Detecting Markers Associated With Endometrial Disease or Phase
#411SCREENING FOR GESTATIONAL DISORDERS
#412Methods and materials for identifying polymorphic variants, diagnosing susceptibilities, and treating disease
#413Methods of reducing the likelihood of spontaneous abortion
#414Method for identifying a patient at risk of having difficulty in sustaining a pregnancy
#415Methods of treating pre-eclampsia and eclampsia
#416Method for Determining the Effectiveness of a Treatment for Preeclampsia
#417Methods for predicting preganancy outcome in a subject by hCG assay
#418METHODS AND KITS FOR PREDICTING RISK FOR PRETERM LABOR
#419Distinguishing Isomers Using Mass Spectrometry
#420Method and Apparatus for Diagnosing Pre-eclampsia
#421Markers of pre-term labor
#422Methods for early detection of pregnancy in cows
#423T1 Receptor-Like Ligand II and Uses Thereof
#424Endometriosis markers
#425Methods And Compositions For The Prevention And Treatment Of Gentiourinary Disorders Including Pre-Term Labor And Leiomyomas
#426Methods for decreasing risk of complications of prematurity using IGF-I and its analogs
#427Immunoassay of Fragments of Insulin-Like Growth Factor Binding Proteins
#428Screen for pre-eclampsia
#429Antiproliferative peptides and antibodies for their detection
#430Bovine pregnancy test
#431Methods of determining whether a pregnant woman is at risk of developing preeclampsia
#432Detecting and predicting pre-eclampsia
#433Compositions and methods for early pregnancy diagnosis
#434METABOLOMIC DETERMINATION IN ASSISTED REPRODUCTIVE TECHNOLOGY
#435Use of ADAM 12 for diagnosis and therapy of preeclampsia
#436Diagnosis of intra-uterine infection by proteomic analysis of cervical-vaginal fluids
#437Methods for diagnosing and for monitoring the treatment of recurrent spontaneous abortion
#438Method to determine state of a cell exchanging metabolites with a fluid medium by analyzing the metabolites in the fluid medium
#439Diagnostic method for proteinaceous binding pairs, cardiovascular conditions and preeclampsia
#440Use of compounds that bind soluble endoglin and SFLT-1 for the treatment of pregnancy related hypertensive disorders
#441Maternal chelation for embryo, fetal, and infant benefit
#442Method of reducing the likelihood of implantation failure during an assisted reproduction in a female subject in a need thereof
#443Marker for inflammatory conditions
#444Diagnosis of pre-eclampsia
#445Method for predicting pregnancy-induced hypertension
#446Determination of pregnancy status in ungulate ruminants
#447Anti-metastin antibody and its use
#448Method of employing elevation of marinobufagenin in determining the presence of preeclampsia and related apparatus
#449Methods of diagnosing fetal trisomy 13 or a risk of fetal trisomy 13 during pregnancy
#450Devices and methods for detecting amniotic fluid in vaginal secretions
#451Non-invasive assessment of intra-amniotic environment
#452Embryo implantation inhibitor
#453Periostin-based diagnostic assays
#454Ectopic pregnancy markers
#455Compositions and method for accurate early pregnancy diagnosis
#456Diagnosis of preeclampsia
#457Method for determination of likelihood of occurrence of preterm labor in pregnant females
#458Labor biomarkers, methods comprising same, and methods targeting same
#459Nucleic acids and polypeptides useful for diagnosing complications of pregnancy
#460EPF derived peptides and therapeutic compositions
#461Compositions and methods for determining oocyte development potential
#462Adherent entities and uses therefor
#463ADAM12, a novel marker for abnormal cell function
#464Biomarkers for intro-amniotic inflammation
#465Marker for inflammatory conditions
#466Method and apparatus for detecting conception in animals
#467Method of detecting early pregnancy at high accuracy by measuring hCG and hyperglycosylated hCG concentrations equally
#468Diagnostic method for screening complement regulatory protein levels to predict spontaneous abortion
#469Diagnosis of fetal aneuploidy
#470Methods of diagnosing and treating complications of pregnancy
#471Method and apparatus for predicting pregnancy outcome
#472Biological marker for inflammation
#473Inhibin-A: a marker for differentiation, diagnosing and screening abnormal pregnancies
#474Method of diagnosis of pregnancy-related complications
#475Non-invasive prenatal genetic diagnosis using transcervical cells
#476Animal model for fetal alcohol syndrome and methods of treatment
#477Detection of oncofetal fibronectin for selection of concepti
#478Oncofetal fibronectin as a marker for pregnancy-related indications
#479Oncofetal fibronectin as a marker for health and disease
#480Methods for detecting oncofetal fibronectin
#481Samples for detection of oncofetal fibronectin and uses thereof
#482Point of care diagnostic systems
#483Point of care diagnostic systems
#484Maternal antibodies as fetal cell markers to identify and enrich fetal cells from maternal blood
#485Methods for diagnosing labor
#486Methods and diagnosis for the treatment of preeclampsia
#487Assays
#488Proteomic method for predicting success of rescue cerclage
#489Blood cell separating system
#490Non-invasive prenatal genetic diagnosis using transcervical cells
#491Methods of diagnosing and treating pre-eclampsia or eclampsia
#492Methods for detecting pregnancy
#493Screening for gestational disorders
#494Screening for gestational disorders
#495Marker for inflammatory conditions
#496Diagnostic method for determining the susceptibility to delivery and reagent kit for use thereof
#497Method for diagnosing increased risk of preeclampsia
#498Pregnancy-related enzyme activity
#499Compositions and methods for early pregnancy diagnosis
#500Multi-marker screening protocol for fetal abnormalities
#501Prenatal diagnosis method on isolated foetal cell of maternal blood
#502Methods for predicting pregnancy outcome in a subject by hCG assay
#503Cadherin-11 as an indicator of viable pregnancy
#504Methods of treating pre-eclampsia or eclampsia
#505Non-invasive prenatal genetic diagnosis using transcervical cells
#506Method of processing a biological sample